SCHEMBL10714733

SCHEMBL10714733

CSC1C(=O)Nc2cc(C)c(-c3ccc([N+](=O)[O-])cc3C)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.43
▸ CYP3A4 P08684 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ GAA P10253 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 3/20 0.38
▸ PGR P06401 1/20 0.38
▸ CAPN9 O14815 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10712773 0.82 TDP1 (0.42) TDP1CYP3A4ALDH1A1KMT2AGAA
SCHEMBL19370850 0.82 PGR (0.50) TDP1CYP3A4ALDH1A1KMT2AGAA
SCHEMBL11427311 0.82 PGR (0.50) TDP1CYP3A4ALDH1A1KMT2AGAA
SCHEMBL10712283 0.77 PGR (0.49) TDP1CYP3A4ALDH1A1KMT2AMAPT
SCHEMBL10713389 0.75 PGR (0.55) TDP1CYP3A4ALDH1A1KMT2AMAPT
SCHEMBL10711722 0.75 PBRM1 (0.35) ALDH1A1KMT2AMAPTMEN1POLB
SCHEMBL10712231 0.73 PGR (0.62) KMT2AGAALMNAMAPTPGR
SCHEMBL30683694 0.72 ALDH1A1 (0.72) TDP1CYP3A4ALDH1A1KMT2ATSHR
SCHEMBL10715133 0.72 PGR (0.72) MAPTPGRTDP2
SCHEMBL10710481 0.67 PGR (0.51) ALDH1A1KMT2ALMNAMAPTPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4670566-A ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-06-02 — — US disclosed
US-4440785-A Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation A. H. ROBINS COMPANY, INC. (US) 1984-04-03 — — US disclosed
Send feedback